BioRestorative Therapies, Inc. Common Stock (NV) (NASDAQ: BRTX) last traded at $0.215, down 2.40% on the session. The quote above updates while this page is open; the figures below are drawn from BioRestorative Therapies, Inc. Common Stock (NV)’s own filings and are restated only when a new one is published.
BioRestorative Therapies, Inc. Common Stock (NV) trades on NASDAQ under the ticker BRTX. Its market capitalisation is $5.49 million.
Valuation measures for BioRestorative Therapies, Inc. Common Stock (NV), derived from the latest quote and its most recent SEC filing.
| Market cap | $5.49M |
|---|---|
| Enterprise value | $6.04M |
| Price / sales | 15.33 |
| Price / book | 1.81 |
| Beta | 1.85 |
Trailing-twelve-month figures tagged in BioRestorative Therapies, Inc. Common Stock (NV)'s XBRL filings with the SEC.
| Revenue (TTM) | $357.9K |
|---|---|
| Net income (TTM) | -$11.06M |
| Gross margin | 92.09% |
| Operating margin | -3975.00% |
| Return on equity | -365.43% |
| Cash | $3.11M |
Range and volume for BRTX over the past 52 weeks.
| 52-week high | $1.89 |
|---|---|
| 52-week low | $0.159 |
| Volume | 75.8K |
| Average volume | 9.71M |
| Previous close | $0.221 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.